Trial Profile
A phase I/II clinical study of AMY-101 in untreated patients with paroxysmal nocturnal hemoglobinuria (PNH)
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs AMY 101 (Primary)
- Indications Paroxysmal nocturnal haemoglobinuria
- Focus Adverse reactions; First in man; Therapeutic Use
- 27 Feb 2017 New trial record